Pharsight

Drugs that contain Sodium Nitrite; Sodium Thiosulfate

1. Nithiodote patents expiration

NITHIODOTE's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US11753301 HOPE PHARMS Sodium thiosulfate-containing pharmaceutical compositions
Feb, 2030

(5 years from now)

US9585912 HOPE PHARMS Sodium thiosulfate-containing pharmaceutical compositions
Jul, 2030

(6 years from now)

US9345724 HOPE PHARMS Sodium thiosulfate-containing pharmaceutical compositions
Jul, 2030

(6 years from now)

US8496973 HOPE PHARMS Sodium thiosulfate-containing pharmaceutical compositions
Mar, 2031

(7 years from now)

US8568793 HOPE PHARMS Sodium nitrite-containing pharmaceutical compositions
Dec, 2031

(7 years from now)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9687506 HOPE PHARMS Sodium nitrite-containing pharmaceutical compositions
Feb, 2030

(5 years from now)

US10479686 HOPE PHARMS Sodium thiosulfate-containing pharmaceutical compositions
Jul, 2030

(6 years from now)

Market Authorisation Date: 14 January, 2011

Treatment: Sodium nitrite injection is administered by intravenous injection; Sodium nitrite injection is indicated for sequential use with sodium thiosulfate for the treatment of acute cyanide poisoning; Sodium...

Dosage: SOLUTION, SOLUTION;INTRAVENOUS, INTRAVENOUS

More Information on Dosage

NITHIODOTE family patents

Family Patents